Mechanisms of inactivation of Schistosoma mansoni and mammalian glutathione S-transferase activity by the antischistosomal drug oltipraz-Reference-Cited by-同舟云学术

Mechanisms of inactivation of Schistosoma mansoni and mammalian glutathione S-transferase activity by the antischistosomal drug oltipraz

Published:1992-03 Issue:6 Volume:43 Page:1345-1351
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Nare Bakela,Smith James M.,Prichard Roger K.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference35 articles.

1. Laboratory studies of 35 972 RP, a new schistosomicidal compound;Leroy,1978

2. One-day treatment of Schistosoma mansoni and Schistosoma haematobium infections with oltipraz (35,972 R.P.);Woehlé,1980

3. Assessment of 35972 RP (oltipraz) a new antischistosomal drug against Schistosoma haematobium, Schistosoma mansoni and Schistosoma intercalatum;Gentilini;Acta Trop (Basel),1980

4. Assessment of oltipraz in schistosomiasis mansoni clinical trial;Katz;Rev Inst Med Trop Sao Paulo,1984

5. Oltipraz—Antischistosomal efficacy in Sudanese infected with Schistosoma mansoni;Bella;Am J Trop Med Hyg,1982

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Potential Effects of Some Indole Compounds on the Glutathione S-Transferase Enzyme;Biochemistry (Moscow);2024-03

2. High-content approaches to anthelmintic drug screening;Trends in Parasitology;2021-09

3. Comparative effectiveness of 4 natural and chemical activators of Nrf2 on inflammation, oxidative stress, macrophage polarization, and bactericidal activity in an in vitro macrophage infection model;PLOS ONE;2020-06-08

4. A Review of Nanotechnology for Targeted Anti-schistosomal Therapy;Frontiers in Bioengineering and Biotechnology;2020-01-31

5. Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators;Cancer Drug Resistance;2020